CN114768001A - Injection method for facial rejuvenation - Google Patents
Injection method for facial rejuvenation Download PDFInfo
- Publication number
- CN114768001A CN114768001A CN202210386121.9A CN202210386121A CN114768001A CN 114768001 A CN114768001 A CN 114768001A CN 202210386121 A CN202210386121 A CN 202210386121A CN 114768001 A CN114768001 A CN 114768001A
- Authority
- CN
- China
- Prior art keywords
- injection
- face
- injection method
- needle
- blood vessels
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002347 injection Methods 0.000 title claims abstract description 75
- 239000007924 injection Substances 0.000 title claims abstract description 75
- 238000000034 method Methods 0.000 title claims abstract description 29
- 238000002676 facial rejuvenation Methods 0.000 title claims abstract description 12
- 210000004204 blood vessel Anatomy 0.000 claims abstract description 22
- 230000003796 beauty Effects 0.000 claims abstract description 14
- 238000007493 shaping process Methods 0.000 claims abstract description 13
- 230000001815 facial effect Effects 0.000 claims abstract description 10
- 238000004140 cleaning Methods 0.000 claims abstract description 7
- 210000003041 ligament Anatomy 0.000 claims abstract description 4
- 238000000638 solvent extraction Methods 0.000 claims abstract description 4
- 239000007788 liquid Substances 0.000 claims description 10
- 230000015624 blood vessel development Effects 0.000 claims description 6
- 229920001432 poly(L-lactide) Polymers 0.000 claims description 6
- 229960005139 epinephrine Drugs 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 3
- 239000008213 purified water Substances 0.000 claims description 3
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 3
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 210000003462 vein Anatomy 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 2
- 241000646858 Salix arbusculoides Species 0.000 claims 1
- 239000002537 cosmetic Substances 0.000 abstract description 2
- 230000000249 desinfective effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 7
- 239000011259 mixed solution Substances 0.000 description 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 3
- 208000005189 Embolism Diseases 0.000 description 3
- 229920002674 hyaluronan Polymers 0.000 description 3
- 229960003160 hyaluronic acid Drugs 0.000 description 3
- 230000037303 wrinkles Effects 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 208000010378 Pulmonary Embolism Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 201000004569 Blindness Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 1
- 206010040893 Skin necrosis Diseases 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 231100000429 cutaneous necrosis Toxicity 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- 210000003657 middle cerebral artery Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000001636 ophthalmic artery Anatomy 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4887—Locating particular structures in or on the body
- A61B5/489—Blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/3286—Needle tip design, e.g. for improved penetration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention relates to the technical field of beauty injection, in particular to an injection technique for facial rejuvenation, which comprises the following steps: s1, evaluating the face aesthetics; s2, cleaning and disinfecting the face; s3, developing the blood vessels below the face; s4, integrally partitioning the face; s5, performing a pumpback test; s6, adopting a V-line multi-dimensional point belt beauty injection method; s7, adopting a slow-withdrawal type safe cosmetic injection method; s8, injecting the facial contour by the principle of lifting and shaping the linear ligament; s9, the nose and the cheek are injected by the three-dimensional increasing shaping principle. The invention develops the blood vessels of the face before injection, avoids the part with more blood vessels and the superfine needle head, slowly withdraws and then injects, thereby improving the safety factor of the operation.
Description
Technical Field
The invention relates to the technical field of beauty treatment injection, in particular to an injection method for facial rejuvenation.
Background
Face rejuvenation: refers to a comprehensive method for changing the main aging characteristics of the face through comprehensive plastic treatment, wherein the injection of poly-L-lactic acid and hyaluronic acid is the main means for resisting the aging of the face.
However, local complications caused by the existing injection mode can have corresponding different clinical consequences on blood vessels at different positions, for example, vascular embolism is one of obvious immediate complications, and for example, when the embolism occurs in an ophthalmic artery (ophtalmartistry), blindness can be developed; cutaneous necrosis (skin necrosis) that occurs in the nasal and dorsally nasal arteries (angular and nasal arteries) can develop; even in cases where it has been reported that embolism may occur in the middle cerebral artery (stroke) and rarely pulmonary embolism (pulmonary embolism) due to chest pain, there is a fatal risk in cases where the stroke is accompanied by a conventional injection.
Therefore, it is an urgent problem to be solved by those skilled in the art to provide an injection method for facial rejuvenation with a high safety factor.
Disclosure of Invention
In order to overcome the above-mentioned disadvantages, the present invention provides an injection method for facial rejuvenation with a high safety factor.
The technical implementation scheme of the invention is as follows:
an injection method for facial rejuvenation comprises the following steps:
s1, cleaning the facial contour skin by using purified water;
s2, performing sterile disinfection on the profile of the face after cleaning;
s3, developing the blood vessels below the face by using a vein developer;
s4, partitioning the whole face part according to the developed blood vessel and the injection part;
s5, performing a retraction test on the needle head during injection;
s6, injecting the facial contour by using a V-line multi-dimensional point belt beauty injection method according to the principle of lifting and shaping a linear ligament, and respectively injecting liquid from outside to inside according to the subareas;
s7, adopting safe slow-drawing type safe cosmetic injection method, drawing a small amount of lidocaine-epinephrine mixed solution as aqueous solution by using injection, and filling the mixed solution carrier in the front needle of the injection;
s8, the nose is subjected to three-dimensional volume-increasing shaping principle, and is injected by a safe instant withdrawing type beauty injection method, the part with more blood vessels is avoided by blood vessel development during injection, and the injection is slowly administered according to the condition of withdrawing the needle;
s9, the cheek is assisted by the point-face three-dimensional highlight bulking shaping principle, the injection is assisted by the safe instant withdrawing type beauty injection method, the part with more blood vessels is avoided by blood vessel development during the injection, and the injection is slowly administered according to the condition of withdrawing the needle.
Preferably, the needle is a superthin needle tip with a willow-leaf-shaped blade surface of Nanoass Jr. (diameter of 0.18 mm).
Preferably, the liquid injected in S7 is poly-L-lactic acid, and the injection amount is 5.0-10.0 ml.
Preferably, the injections in S9 and S10 are sodium hyaluronate gel for injection.
The invention has the following advantages:
according to the invention, the blood vessels on the face are developed before injection, the part with more blood vessels is avoided, and the injection is carried out by adopting the needle with the diameter of 0.18mm, so that the damage of the needle to the blood vessels in the injection process is reduced, and meanwhile, lidocaine-epinephrine mixed solution is injected through the needle point and injected after slow pumping back, so that the operation comfort and the safety coefficient are improved.
Detailed Description
Reference herein to an embodiment means that a particular feature, structure, or characteristic described in connection with the embodiment can be included in at least one embodiment of the invention. The appearances of the phrase in various places in the specification are not necessarily all referring to the same embodiment, nor are separate or alternative embodiments mutually exclusive of other embodiments. It is explicitly and implicitly understood by one skilled in the art that the embodiments described herein can be combined with other embodiments.
Examples
An injection method for facial rejuvenation comprises the following steps:
s1, cleaning the facial contour skin by using purified water;
s2, performing sterile disinfection on the profile of the face after cleaning;
s3, developing the blood vessels below the face by using a vein developer;
s4, partitioning the whole face part according to the developed blood vessel and the injection part;
s5, performing a retraction test on the needle head during injection;
s6, injecting the facial contour by using a V-line multi-dimensional point belt beauty injection method according to the principle of lifting and shaping a linear ligament, and respectively injecting liquid from outside to inside according to the subareas;
s7, adopting safe slow-withdrawing safe beauty injection method, using injection to withdraw small amount of lidocaine-epinephrine as liquid, to make the front needle of injection full of mixed liquid carrier;
s8, carrying out injection on the nose according to the principle of three-dimensional volume-increasing shaping and the assistance of a safe instant drawing-back type beauty injection method, avoiding the part with more blood vessels distribution through blood vessel development during injection, and slowly administering the medicine according to the condition of withdrawing the needle;
s9, injecting the mixture by a point-face three-dimensional highlight bulking shaping principle and a safe instant back-drawing type beauty injection method, avoiding the part with more blood vessels by blood vessel development during injection, and slowly administering the medicament according to the condition of withdrawing the needle.
To further optimize the above protocol, the needle was a super fine tip with a willowleaf-shaped facet of nanonus jr. (nanopoass Jr. diameter 0.18 mm).
In order to further optimize the scheme, the liquid injected in S7 is poly-L-lactic acid, and the injection amount is 5.0-10.0 ml.
In order to further optimize the scheme, the injections in S9 and S10 are sodium hyaluronate gel for injection.
In order to further optimize the scheme, the poly-L-lactic acid, abbreviated as PLLA, is a biodegradable high polymer material, is injected into a body and finally degraded into carbon dioxide and water, enters skin tissues to release signals, stimulates fibroblasts to secrete collagen, and improves facial wrinkles and depressions; through injection to the deep layer of the dermis, the effects of repairing the appearance and correcting the contour so as to achieve the effects of tightening, fine and plump skin are achieved. No swelling, no influence on work and learning, namely, do and walk.
In order to further optimize the scheme, the hyaluronic acid is an internationally-certified injection filling material, has the characteristics of filling and shaping, repairing wrinkles and stimulating the regeneration of autologous collagen, comprehensively shapes three-dimensional and personalized exquisite five sense organs and facial contours by combining with the aesthetic standard of the face, and can effectively remove various facial wrinkles and improve the texture of the skin while injection shaping is performed. Hyaluronic acid can repair the conditions of skin tissue depression, soft tissue defect and the like, and can enable the skin of a beauty-seeking person to be restored to a full and smooth state. The filling part comprises temples, cheeks, and zygomatic bone depression.
According to the invention, the blood vessels on the face are developed before injection, the part with more blood vessels is avoided, the needle with the diameter of 0.18mm is adopted for injection, so that the damage of the needle to the blood vessels in the injection process is reduced, and meanwhile, lidocaine-epinephrine mixed solution is injected through the needle point and injected after being slowly pumped back, so that the operation comfort degree and the safety factor are improved.
The above description is only for the specific embodiments of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art can easily conceive of the changes or substitutions within the technical scope of the present invention, and all the changes or substitutions should be covered within the scope of the present invention. Therefore, the protection scope of the present invention shall be subject to the protection scope of the claims.
Claims (4)
1. An injection method for facial rejuvenation, comprising the steps of:
s1, cleaning the facial contour skin by using purified water;
s2, performing sterile disinfection on the outline of the face after cleaning;
s3, developing the blood vessels below the face by using a vein developer;
s4, partitioning the whole face part according to the developed blood vessel and the injection part;
s5, performing a retraction test on the needle head during injection;
s6, injecting the facial contour by using a V-line multi-dimensional point belt beauty injection method according to the principle of lifting and shaping a linear ligament, and injecting liquid from outside to inside according to zones;
s7, adopting safe slow-withdrawing safe beauty injection method, using injection to withdraw small amount of lidocaine-epinephrine as liquid, to make the front needle of injection full of mixed liquid carrier;
s8, the nose is subjected to three-dimensional volume-increasing shaping principle, and is injected by a safe instant withdrawing type beauty injection method, the part with more blood vessels is avoided by blood vessel development during injection, and the injection is slowly administered according to the condition of withdrawing the needle;
s9, the cheek is assisted by the point-face three-dimensional highlight bulking shaping principle, the injection is assisted by the safe instant withdrawing type beauty injection method, the part with more blood vessels is avoided by blood vessel development during the injection, and the injection is slowly administered according to the condition of withdrawing the needle.
2. An injection method for facial rejuvenation as claimed in claim 1 wherein the needle is a super fine needle with a willow leaf-shaped cutting surface of Nanoass Jr. (diameter 0.18 mm).
3. The injection method for facial rejuvenation as set forth in claim 1, wherein the liquid injected in S7 is poly-L-lactic acid, and the injection amount is 5.0 to 10.0 ml.
4. The injection method for facial rejuvenation as set forth in claim 1, wherein the injection material in S9 and S10 is sodium hyaluronate gel for injection.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210386121.9A CN114768001A (en) | 2022-04-13 | 2022-04-13 | Injection method for facial rejuvenation |
| CN202410107671.1A CN117959525A (en) | 2022-04-13 | 2022-04-13 | Injection technique for face rejuvenation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210386121.9A CN114768001A (en) | 2022-04-13 | 2022-04-13 | Injection method for facial rejuvenation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202410107671.1A Division CN117959525A (en) | 2022-04-13 | 2022-04-13 | Injection technique for face rejuvenation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114768001A true CN114768001A (en) | 2022-07-22 |
Family
ID=82428726
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202410107671.1A Pending CN117959525A (en) | 2022-04-13 | 2022-04-13 | Injection technique for face rejuvenation |
| CN202210386121.9A Pending CN114768001A (en) | 2022-04-13 | 2022-04-13 | Injection method for facial rejuvenation |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202410107671.1A Pending CN117959525A (en) | 2022-04-13 | 2022-04-13 | Injection technique for face rejuvenation |
Country Status (1)
| Country | Link |
|---|---|
| CN (2) | CN117959525A (en) |
-
2022
- 2022-04-13 CN CN202410107671.1A patent/CN117959525A/en active Pending
- 2022-04-13 CN CN202210386121.9A patent/CN114768001A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN117959525A (en) | 2024-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Keen | Hyaluronic acid in dermatology | |
| US20060040895A1 (en) | Aesthetic use of hyaluronan | |
| EP2606828B1 (en) | Hyaluronic acid and its use for treating venous insufficiency and varicose veins | |
| Palomar-Gallego et al. | Influence of the topographic vascular distribution of the face on dermal filler accidents | |
| CN113855930A (en) | A skin caring injection method for removing wrinkle and regenerating collagen by hand injection | |
| CN114768001A (en) | Injection method for facial rejuvenation | |
| US20220395455A1 (en) | Methods and processes for enhancing the aesthetic appearance of a face | |
| Torres | Nasal volumetric remodelling with the aid of a new, stabilised hyaluronic acid dermal filler | |
| CN113694309A (en) | Beauty treatment injection method adopting T-line multi-dimensional point belt | |
| Almutairi et al. | Treacherous territory: Temple fillers and tissue necrosis | |
| CN113425341A (en) | Periocular combined anti-aging operation avoiding blood vessels and preventing bruise | |
| Wu | Injection Rhinoplasty–Aesthetic Considerations and the Anatomical Basis for Safe Injection Techniques | |
| CN111202842A (en) | Pharmaceutical composition for treating hyaluronic acid vascular embolism | |
| Pratama et al. | The Current Art Combination of Platelet-Rich Plasma and Poly-D, L-Lactic Acid for Improvement of Deep Nasolabial Folds: A Case Report | |
| CN111419780A (en) | Facial composition and application thereof | |
| CN114432541A (en) | Cosmetic injection method adopting injection and lifting in front of ears | |
| Li et al. | Clinical effects of injectable collagen in lower-lid pretarsal fullness rejuvenation | |
| Hwang et al. | Nonsurgical Brow and Eyelid Rejuvenation | |
| Zhou et al. | Clinical efficacy and safety of composite non‐cross‐linked hyaluronic acid for treating tear trough‐lower eyelid bag deformity | |
| CN113694310A (en) | Triangular lattice beauty injection method and beauty injection for autologous collagen regeneration | |
| CN113855931A (en) | Beautifying injection method for shaping eyebrows and lifting eyebrows | |
| Ahmad Nasrollahi et al. | Comparative clinical assessment of two nasolabial hyaluronic acid fillers: A double-blind, randomized controlled trial | |
| Türsen | Treatment of nasolabial folds with fillers | |
| Pavicic et al. | The temple and forehead | |
| CN114432544A (en) | Beauty injection method and skin regeneration beauty injection using multi-dimensional mesh line carving |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220722 |
|
| RJ01 | Rejection of invention patent application after publication |